HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-MAR-12 4E73 TITLE CRYSTAL STRUCTURE OF JNK1BETA-JIP IN COMPLEX WITH AN AZAQUINOLONE TITLE 2 INHBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 8; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 8, MAPK 8, JNK-46, STRESS-ACTIVATED PROTEIN COMPND 5 KINASE 1C, SAPK1C, STRESS-ACTIVATED PROTEIN KINASE JNK1, C-JUN N- COMPND 6 TERMINAL KINASE 1; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: C-JUN-AMINO-TERMINAL KINASE-INTERACTING PROTEIN 1; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: JIP-1, JNK-INTERACTING PROTEIN 1, ISLET-BRAIN 1, IB-1, JNK COMPND 13 MAP KINASE SCAFFOLD PROTEIN 1, MITOGEN-ACTIVATED PROTEIN KINASE 8- COMPND 14 INTERACTING PROTEIN 1; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK8, JNK1, PRKM8, SAPK1, SAPK1C; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.M.LUKACS,C.A.JANSON REVDAT 3 13-SEP-23 4E73 1 REMARK SEQADV REVDAT 2 24-SEP-14 4E73 1 JRNL REVDAT 1 29-MAY-13 4E73 0 JRNL AUTH N.E.HAYNES,N.R.SCOTT,L.C.CHEN,C.A.JANSON,J.K.LI,C.M.LUKACS, JRNL AUTH 2 A.RAILKAR,E.TOZZO,T.WHITTARD,N.F.BROWN,A.W.CHEUNG JRNL TITL IDENTIFICATION OF AN ADAMANTYL AZAQUINOLONE JNK SELECTIVE JRNL TITL 2 INHIBITOR. JRNL REF ACS MED CHEM LETT V. 3 764 2012 JRNL REFN ISSN 1948-5875 JRNL PMID 24900545 JRNL DOI 10.1021/ML300175C REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1131880.990 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 20301 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1035 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2510 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2490 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1035 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0090 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 20301 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3180 REMARK 3 BIN R VALUE (WORKING SET) : 0.3040 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 175 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2645 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 89 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.28000 REMARK 3 B22 (A**2) : -4.23000 REMARK 3 B33 (A**2) : 3.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.35 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.650 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.650 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.790 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.110 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.110 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 64.55 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARA REMARK 3 PARAMETER FILE 2 : LIG.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIG.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4E73 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAR-12. REMARK 100 THE DEPOSITION ID IS D_1000071251. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20514 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 27.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 27.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.48800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1UKH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13-16% PEG 3350, 0.1M ADA PH 6.0, 10 REMARK 280 MM DTT, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.45050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.76200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.92000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.76200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.45050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.92000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 SER A 4 REMARK 465 LYS A 5 REMARK 465 ARG A 6 REMARK 465 ASP A 7 REMARK 465 ARG A 174 REMARK 465 THR A 175 REMARK 465 ALA A 176 REMARK 465 GLY A 177 REMARK 465 THR A 178 REMARK 465 SER A 179 REMARK 465 PHE A 180 REMARK 465 MET A 181 REMARK 465 MET A 182 REMARK 465 THR A 183 REMARK 465 PRO A 184 REMARK 465 TYR A 185 REMARK 465 VAL A 186 REMARK 465 VAL A 187 REMARK 465 THR A 188 REMARK 465 ALA A 282 REMARK 465 ASP A 283 REMARK 465 SER A 284 REMARK 465 GLU A 285 REMARK 465 HIS A 286 REMARK 465 ASN A 287 REMARK 465 LYS A 288 REMARK 465 LEU A 289 REMARK 465 ALA A 332 REMARK 465 PRO A 333 REMARK 465 PRO A 334 REMARK 465 PRO A 335 REMARK 465 LYS A 336 REMARK 465 ILE A 337 REMARK 465 PRO A 338 REMARK 465 ASP A 339 REMARK 465 LYS A 340 REMARK 465 GLN A 341 REMARK 465 LEU A 342 REMARK 465 ASP A 343 REMARK 465 GLU A 344 REMARK 465 ASP A 362 REMARK 465 LEU A 363 REMARK 465 HIS A 364 REMARK 465 HIS A 365 REMARK 465 HIS A 366 REMARK 465 HIS A 367 REMARK 465 HIS A 368 REMARK 465 HIS A 369 REMARK 465 LYS B 153 REMARK 465 PHE B 163 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 59 69.00 35.26 REMARK 500 HIS A 82 144.12 -171.15 REMARK 500 PHE A 101 116.20 -37.29 REMARK 500 GLN A 102 -55.63 -124.35 REMARK 500 MET A 111 -159.20 -104.55 REMARK 500 ARG A 150 -5.48 71.21 REMARK 500 ILE A 219 -60.91 -97.78 REMARK 500 PRO A 246 -83.30 -46.44 REMARK 500 GLU A 247 37.89 34.87 REMARK 500 PHE A 248 -51.05 158.41 REMARK 500 ARG A 263 151.18 -45.54 REMARK 500 ALA A 291 -74.54 42.71 REMARK 500 LYS B 155 97.82 47.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 246 GLU A 247 102.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0NR A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UKH RELATED DB: PDB DBREF 4E73 A 1 363 UNP P45983 MK08_HUMAN 1 363 DBREF 4E73 B 153 163 UNP Q9UQF2 JIP1_HUMAN 157 167 SEQADV 4E73 HIS A 364 UNP P45983 EXPRESSION TAG SEQADV 4E73 HIS A 365 UNP P45983 EXPRESSION TAG SEQADV 4E73 HIS A 366 UNP P45983 EXPRESSION TAG SEQADV 4E73 HIS A 367 UNP P45983 EXPRESSION TAG SEQADV 4E73 HIS A 368 UNP P45983 EXPRESSION TAG SEQADV 4E73 HIS A 369 UNP P45983 EXPRESSION TAG SEQADV 4E73 LYS B 153 UNP Q9UQF2 ARG 157 CONFLICT SEQRES 1 A 369 MET SER ARG SER LYS ARG ASP ASN ASN PHE TYR SER VAL SEQRES 2 A 369 GLU ILE GLY ASP SER THR PHE THR VAL LEU LYS ARG TYR SEQRES 3 A 369 GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE SEQRES 4 A 369 VAL CYS ALA ALA TYR ASP ALA ILE LEU GLU ARG ASN VAL SEQRES 5 A 369 ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR SEQRES 6 A 369 HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET LYS SEQRES 7 A 369 CYS VAL ASN HIS LYS ASN ILE ILE GLY LEU LEU ASN VAL SEQRES 8 A 369 PHE THR PRO GLN LYS SER LEU GLU GLU PHE GLN ASP VAL SEQRES 9 A 369 TYR ILE VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN SEQRES 10 A 369 VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER TYR SEQRES 11 A 369 LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SEQRES 12 A 369 SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 369 ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP SEQRES 14 A 369 PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET MET SEQRES 15 A 369 THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU SEQRES 16 A 369 VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP ILE SEQRES 17 A 369 TRP SER VAL GLY CYS ILE MET GLY GLU MET ILE LYS GLY SEQRES 18 A 369 GLY VAL LEU PHE PRO GLY THR ASP HIS ILE ASP GLN TRP SEQRES 19 A 369 ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO GLU SEQRES 20 A 369 PHE MET LYS LYS LEU GLN PRO THR VAL ARG THR TYR VAL SEQRES 21 A 369 GLU ASN ARG PRO LYS TYR ALA GLY TYR SER PHE GLU LYS SEQRES 22 A 369 LEU PHE PRO ASP VAL LEU PHE PRO ALA ASP SER GLU HIS SEQRES 23 A 369 ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SER SEQRES 24 A 369 LYS MET LEU VAL ILE ASP ALA SER LYS ARG ILE SER VAL SEQRES 25 A 369 ASP GLU ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP TYR SEQRES 26 A 369 ASP PRO SER GLU ALA GLU ALA PRO PRO PRO LYS ILE PRO SEQRES 27 A 369 ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU GLU SEQRES 28 A 369 TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASP LEU HIS SEQRES 29 A 369 HIS HIS HIS HIS HIS SEQRES 1 B 11 LYS PRO LYS ARG PRO THR THR LEU ASN LEU PHE HET 0NR A 401 42 HETNAM 0NR METHYL 3-(4-{[(1R,2S,3S,5S,7S)-5- HETNAM 2 0NR AMINOTRICYCLO[3.3.1.1~3,7~]DEC-2-YL]CARBAMOYL}BENZYL)- HETNAM 3 0NR 4-OXO-1-PHENYL-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-2- HETNAM 4 0NR CARBOXYLATE FORMUL 3 0NR C34 H34 N4 O4 FORMUL 4 HOH *89(H2 O) HELIX 1 1 ASN A 63 VAL A 80 1 18 HELIX 2 2 LEU A 115 GLN A 120 1 6 HELIX 3 3 ASP A 124 ALA A 145 1 22 HELIX 4 4 LYS A 153 SER A 155 5 3 HELIX 5 5 ALA A 193 LEU A 198 1 6 HELIX 6 6 ASN A 205 GLY A 221 1 17 HELIX 7 7 ASP A 229 GLY A 242 1 14 HELIX 8 8 CYS A 245 LYS A 250 1 6 HELIX 9 9 GLN A 253 ARG A 263 1 11 HELIX 10 10 SER A 270 PHE A 275 1 6 HELIX 11 11 PRO A 276 PHE A 280 5 5 HELIX 12 12 ALA A 291 LEU A 302 1 12 HELIX 13 13 ASP A 305 ARG A 309 5 5 HELIX 14 14 SER A 311 HIS A 318 1 8 HELIX 15 15 HIS A 318 VAL A 323 1 6 HELIX 16 16 THR A 348 MET A 361 1 14 SHEET 1 A 2 PHE A 10 ILE A 15 0 SHEET 2 A 2 SER A 18 LEU A 23 -1 O SER A 18 N ILE A 15 SHEET 1 B 5 TYR A 26 GLY A 35 0 SHEET 2 B 5 GLY A 38 ASP A 45 -1 O ALA A 42 N LYS A 30 SHEET 3 B 5 ARG A 50 LEU A 57 -1 O VAL A 52 N ALA A 43 SHEET 4 B 5 TYR A 105 GLU A 109 -1 O MET A 108 N ALA A 53 SHEET 5 B 5 LEU A 88 PHE A 92 -1 N LEU A 89 O VAL A 107 SHEET 1 C 3 ALA A 113 ASN A 114 0 SHEET 2 C 3 ILE A 157 VAL A 159 -1 O VAL A 159 N ALA A 113 SHEET 3 C 3 LEU A 165 ILE A 167 -1 O LYS A 166 N VAL A 158 SITE 1 AC1 17 ILE A 32 GLY A 33 VAL A 40 ALA A 42 SITE 2 AC1 17 ALA A 53 MET A 108 GLU A 109 MET A 111 SITE 3 AC1 17 ASP A 112 ALA A 113 ASN A 114 VAL A 158 SITE 4 AC1 17 LEU A 168 ASN A 262 HOH A 518 HOH A 573 SITE 5 AC1 17 HOH A 577 CRYST1 62.901 79.840 85.524 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015898 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012525 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011693 0.00000